The weight lowering effect of sibutramine and its impact on serum lipids in cardiovascular high risk patients with and without type 2 diabetes mellitus - an analysis from the SCOUT lead-in period

Peter Weeke; Charlotte Andersson; Emil L Fosbøl; Bente Brendorp; Lars Køber; Arya M Sharma; Nick Finer; Philip James Douglass; Ian D Caterson; Richard A Rode; Christian Torp-Pedersen

doi:10.1186/1472-6823-10-3

The weight lowering effect of sibutramine and its impact on serum lipids in cardiovascular high risk patients with and without type 2 diabetes mellitus - an analysis from the SCOUT lead-in period

Peter Weeke, Charlotte Andersson, Emil L Fosbøl, Bente Brendorp, Lars Køber, Arya M Sharma, Nick Finer, Philip James Douglass, Ian D Caterson, Richard A Rode, Christian Torp-Pedersen

Medicinsk Afdeling GLO

18 Citationer (Scopus)

Abstract

ABSTRACT:

Originalsprog	Engelsk
Tidsskrift	B M C Endocrine Disorders
Vol/bind	10
Sider (fra-til)	3
ISSN	1472-6823
DOI	https://doi.org/10.1186/1472-6823-10-3
Status	Udgivet - 1 jan. 2010

Adgang til dokumentet

10.1186/1472-6823-10-3

Citationsformater

Weeke, P., Andersson, C., Fosbøl, E. L., Brendorp, B., Køber, L., Sharma, A. M., Finer, N., Douglass, P. J., Caterson, I. D., Rode, R. A., & Torp-Pedersen, C. (2010). The weight lowering effect of sibutramine and its impact on serum lipids in cardiovascular high risk patients with and without type 2 diabetes mellitus - an analysis from the SCOUT lead-in period. B M C Endocrine Disorders, 10, 3. https://doi.org/10.1186/1472-6823-10-3

The weight lowering effect of sibutramine and its impact on serum lipids in cardiovascular high risk patients with and without type 2 diabetes mellitus - an analysis from the SCOUT lead-in period. / Weeke, Peter; Andersson, Charlotte; Fosbøl, Emil L et al.
I: B M C Endocrine Disorders, Bind 10, 01.01.2010, s. 3.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Weeke, P, Andersson, C, Fosbøl, EL, Brendorp, B, Køber, L, Sharma, AM, Finer, N, Douglass, PJ, Caterson, ID, Rode, RA & Torp-Pedersen, C 2010, 'The weight lowering effect of sibutramine and its impact on serum lipids in cardiovascular high risk patients with and without type 2 diabetes mellitus - an analysis from the SCOUT lead-in period', B M C Endocrine Disorders, bind 10, s. 3. https://doi.org/10.1186/1472-6823-10-3

@article{8649f60e9d7f4f71aff382ffcfccfbb2,

title = "The weight lowering effect of sibutramine and its impact on serum lipids in cardiovascular high risk patients with and without type 2 diabetes mellitus - an analysis from the SCOUT lead-in period",

abstract = "ABSTRACT:",

author = "Peter Weeke and Charlotte Andersson and Fosb{\o}l, {Emil L} and Bente Brendorp and Lars K{\o}ber and Sharma, {Arya M} and Nick Finer and Douglass, {Philip James} and Caterson, {Ian D} and Rode, {Richard A} and Christian Torp-Pedersen",

year = "2010",

month = jan,

day = "1",

doi = "10.1186/1472-6823-10-3",

language = "English",

volume = "10",

pages = "3",

journal = "B M C Endocrine Disorders",

issn = "1472-6823",

publisher = "BioMed Central Ltd",

}

TY - JOUR

T1 - The weight lowering effect of sibutramine and its impact on serum lipids in cardiovascular high risk patients with and without type 2 diabetes mellitus - an analysis from the SCOUT lead-in period

AU - Weeke, Peter

AU - Andersson, Charlotte

AU - Fosbøl, Emil L

AU - Brendorp, Bente

AU - Køber, Lars

AU - Sharma, Arya M

AU - Finer, Nick

AU - Douglass, Philip James

AU - Caterson, Ian D

AU - Rode, Richard A

AU - Torp-Pedersen, Christian

PY - 2010/1/1

Y1 - 2010/1/1

N2 - ABSTRACT:

AB - ABSTRACT:

U2 - 10.1186/1472-6823-10-3

DO - 10.1186/1472-6823-10-3

M3 - Journal article

C2 - 20184783

SN - 1472-6823

VL - 10

SP - 3

JO - B M C Endocrine Disorders

JF - B M C Endocrine Disorders

ER -

The weight lowering effect of sibutramine and its impact on serum lipids in cardiovascular high risk patients with and without type 2 diabetes mellitus - an analysis from the SCOUT lead-in period

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater